Veradermics MANE
NYSE MANE
$117.54 +2.54 (+2.21%)
As of: Sep 29, 2026 · 3:59 PM EDT

Veradermics (MANE) Total Liabilities (2024 - 2026)

Updated

Veradermics (MANE) reported Total Liabilities of $12.12 million for Q2 2026, up 80.5% from the prior quarter.

Analysis

Veradermics (MANE) Total Liabilities (2024 - 2026) Analysis & Trends

At the end of FY2025, Veradermics posted Total Liabilities of $273.63 million, up 163.1% from FY2024.

  • By year, Total Liabilities came in at $104.02 million in FY2024.
  • Five-year quarterly Total Liabilities spans a low of $6.72 million in Q1 2026 and a high of $273.63 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 116.09 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 141.05 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 87.82 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 80.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 65.46 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 83.95 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 37.53 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 115.64 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 7.18 Bn
10 Veradermics 4.80 Bn 4.80 Bn - 12.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.12 Mn
Mar 31, 2026 6.72 Mn
Dec 31, 2025 273.63 Mn
Dec 31, 2024 104.02 Mn
API Access

Veradermics Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=MANE&period=max&api_key=YOUR_API_KEY